Professor of Medicinal Chemistry and Molecular Pharmacology

Program Co-Leader of Cell Identity and Signaling of Purdue University

             Center for Cancer Research (PCCR)

Program Co-Leader of Prostate Cancer Discovery Group of PCCR

 

Phone: (765) 496-1971

Fax: (765) 494-1414

E-mailhu1@purdue.edu

Purdue Faculty Websitehttps://www.mcmp.purdue.edu/faculty/hu1

Specialization: Cancer Biology and Cancer Pharmacology

 
Education

M.D. (1984) - Bengbu Medical College, China (Medicine)
M.S. (1987) - Tongji Medical University, China (Cancer Immunology)
Ph.D. (1997) - Kobe University, Japan (Molecular Biology)
Postdoc (2000-2002) - University of Michigan

 

Recent Awards

July 2017 - June 2021 - University Showalter Faculty Scholar Award of Purdue University

                    May 2019 - 2019 Chaney Faculty Scholar Award (Research Award in the Purdue University College of Pharmacy)

                    May 2018 - Lafayette Lions Club Award for Outstanding Achievements in Cancer Research (State Award)

              October 2017 - Seed for Success Award (EVPRP)

                   April 2017 - Pharmaceutical Sciences Teacher of the Year in the College of Pharmacy

 

Research Areas

(1)  Development of novel technologies to image and target transcriptional and epigenetic regulation.

(2)  Regulation and function of AP-1 in prostate cancer cells. 

(3)  Mechanisms and targeting of therapy-induced neuroendocrine differentiation (NED) in prostate cancer. 

(4)  Role of PRMT5 in prostate cancer development, progression, and therapeutic response. 

(5)  Development of protein-protein interaction disruptors as novel cancer therapeutics. 

Professor Chang-Deng Hu, M.D., Ph.D.

Chang-Deng Hu Full CV
  • Facebook Clean Grey
  • Twitter Clean Grey